glp-1 obesity drug news october 21 2025 Weight-loss drugs such as Ozempic were in the headlines a lot in – and patent protections for these drugs expire in some countries in 2026. In this edition of #PeriodicGraphics in @ GLP-1 Agonists Weight Loss Drugs
Description
October 2024 The GLP-1 receptor agonist drug class has revolutionized obesity treatment, and has spurred investment and innovation across the pharmaceutical industry
21 FDA (2022)
Interested in advocating for people living with T1D
The link between cognition and somatic conditions related to insulin resistance in the UK biobank study cohort: a systematic review
Development Speed and Consistency: Chemical synthesis is generally and highly reproducible, faster for straightforward, short peptides
